Alzheimers Drugs Market by Drug Class , by Distribution Channel , and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

  • ID: 4531791
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 3
The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along with the impact they have on the demand over the forecast period.

Additionally, the report includes the study of opportunities available in the Alzheimers drugs market on a global level.In order to give the users of this report a comprehensive view on the Alzheimers drugs market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses drug class, distribution channel and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view on the Alzheimers drugs market by segmenting the market based on drug class, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022.

Based on Drug Class, Alzheimers drugs market has been segmented into cholinergic, memantine and combined drug. Based on distribution channel, Alzheimers drugs market have been segmented into hospital pharmacy, retail pharmacy, and online sales. Growing occurrence of diseases in developed western countries, the prevalence of the number of neurodegenerative diseases such as dementia has grown in countries such as the U.S, steady government support for Alzheimers drug development, and growing awareness about the treatment of Alzheimers disease, are some of the factors that drive the market growth during the forecast period. Additionally, growing geriatric population are the major factors which drive the patient segment in Alzheimers drugs market with highest CAGR during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Mexico, Germany, Spain, Italy, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for Alzheimers drugs market based on individual segment and applications in all the regions and countries. The report also includes detailed profiles of end players such as Ono Pharmaceutical, Johnson Johnson, Daiichi Sankyo Company Limited, H Lundbeck A/S, Eisai Co Ltd., and among others.

This report segments the global Alzheimers drugs market as follows:

Global Alzheimers Drugs Market: by Drug Class
Cholinergic
Memantine
Combined Drug

Global Alzheimers Drugs Market: by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales

Global Alzheimers Drugs Market: by Region
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

2. Executive Summary
2.1. Global Alzheimers drugs market, 2014 2022 (USD Billion)
2.2. Global Alzheimers drugs market: Snapshot

3. Alzheimers Drugs Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global Alzheimers drugs market drivers: Impact analysis
3.2.2. Growing occurrence of diseases in developed western countries
3.2.3. Steady government support for Alzheimers drug development, growing awareness about treatment of Alzheimers disease
3.3. Market restraints
3.3.1. High prices of advanced drugs
3.3.2. Awareness about Alzheimers disease remains limited in developing countries like Southeast Asia
3.4. Opportunities
3.4.1. Growing support for mental care infrastructure from governments in several developing Asia Pacific countries is thus likely to drive the Alzheimers drugs market in he region in the coming years.
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by Drug Class
3.6.2. Market attractiveness analysis, by Distribution Channel
3.6.3. Market attractiveness analysis, by Regional Segment

4. Global Alzheimers Drugs Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global Alzheimers drugs market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Drug Class Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Regional Expansion

5. Global Alzheimers Drugs Market Drug Class Segment Analysis
5.1. Global Alzheimers drugs market: Drug Class overview
5.1.1. Global Alzheimers drugs market revenue share, by Drug Class, 2014 and 2022(USD Billion)
5.2. Cholinergic
5.2.1. Global Cholinergic drugs market, 2014 2022(USD Billion)
5.3. Memantine
5.3.1. Global Memantine drugs market, 2014 2022(USD Billion)
5.4. Combined Drug
5.4.1. Global Combined drugs market, 2014 2022(USD Billion)

6. Global Alzheimers Drugs Market Distribution Channel Segment Analysis
6.1. Global Alzheimers drugs market: Distribution Channel overview
6.1.1. Global Alzheimers drugs market revenue share, by Distribution Channel, 2014 and 2022(USD Billion)
6.2. Hospital Pharmacy
6.2.1. Global Alzheimers drugs market for Hospital Pharmacy , 2014 2022(USD Billion)
6.3. Retail Pharmacy
6.3.1. Global Alzheimers drugs market for Retail Pharmacy, 2014 2022(USD Billion)
6.4. Online Sales
6.4.1. Global Alzheimers drugs market for Online Sales, 2014 2022(USD Billion)

7. Global Alzheimers Drugs Market Regional Segment Analysis
7.1. Global Alzheimers drugs market: Regional overview
7.1.1. Global Alzheimers drugs market revenue share, by Region, 2015 and 2021
7.2. North America
7.2.1. North America Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.2.2. North America Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.2.3. North America Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.2.4. U.S.
7.2.4.1. U.S. Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.2.4.2. U.S. Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.2.4.3. U.S. Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.2.5. Canada
7.2.5.1. Canada Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.2.5.2. Canada Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.2.5.3. Canada Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3. Europe
7.3.1. Europe Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.2. Europe Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.3. Europe Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.4. Germany
7.3.4.1. Germany Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.4.2. Germany Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.4.3. Germany Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.5. U.K.
7.3.5.1. U.K. Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.5.2. U.K. Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.5.3. U.K. Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.6. France
7.3.6.1. France Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.6.2. France Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.6.3. France Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.7. Italy
7.3.7.1. Italy Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.7.2. Italy Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.7.3. Italy Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.8. Spain
7.3.8.1. Spain Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.8.2. Spain Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.8.3. Spain Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.9. Russia
7.3.9.1. Russia Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.9.2. Russia Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.9.3. Russia Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.3.10. Rest of Europe
7.3.10.1. Rest of Europe Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.3.10.2. Rest of Europe Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.3.10.3. Rest of Europe Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.2. Asia Pacific Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.3. Asia Pacific Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.4.4. China
7.4.4.1. China Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.4.2. China Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.4.3. China Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.4.5. Japan
7.4.5.1. Japan Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.5.2. Japan Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.5.3. Japan Alzheimers drugs market revenue, by region, 2014 2022(USD Billion)
7.4.6. India
7.4.6.1. India Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.6.2. India Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.6.3. India Alzheimers drugs market revenue, by region, 2014 2022(USD Billion)
7.4.7. Australia
7.4.7.1. Australia Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.7.2. Australia Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.7.3. Australia Alzheimers drugs market revenue, by region, 2014 2022(USD Billion)
7.4.8. Rest of Asia Pacific
7.4.8.1. Rest of Asia Pacific Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.4.8.2. Rest of Asia Pacific Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.4.8.3. Rest of Asia Pacific Alzheimers drugs market revenue, by region, 2014 2022(USD Billion)
7.5. Latin America
7.5.1. Latin America Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.5.2. Latin America Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.5.3. Latin America Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.5.4. Mexico
7.5.4.1. Mexico Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.5.4.2. Mexico Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.5.4.3. Mexico Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.5.5. Brazil
7.5.5.1. Brazil Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.5.5.2. Brazil Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.5.5.3. Brazil Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.5.6. Argentina
7.5.6.1. Argentina Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.5.6.2. Argentina Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.5.6.3. Argentina Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.5.7. Rest of Latin America
7.5.7.1. Rest of Latin America Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.5.7.2. Rest of Latin America Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.5.7.3. Rest of Latin America Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.2. Middle East and Africa Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.3. Middle East and Africa Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6.4. Saudi Arabia
7.6.4.1. Saudi Arabia Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.4.2. Saudi Arabia Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.4.3. Saudi Arabia Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6.5. UAE
7.6.5.1. UAE Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.5.2. UAE Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.5.3. UAE Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6.6. South Africa
7.6.6.1. South Africa Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.6.2. South Africa Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.6.3. South Africa Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6.7. Qatar
7.6.7.1. Qatar Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.7.2. Qatar Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.7.3. Qatar Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)
7.6.8. Rest of Middle East and Africa
7.6.8.1. Rest of Middle East and Africa Alzheimers drugs market revenue, by Drug Class, 2014 2022(USD Billion)
7.6.8.2. Rest of Middle East and Africa Alzheimers drugs market revenue, by Distribution Channel, 2014 2022(USD Billion)
7.6.8.3. Rest of Middle East and Africa Alzheimers drugs market revenue, by Region, 2014 2022(USD Billion)

8. Company Profile
8.1. Ono Pharmaceutical
8.1.1. Overview
8.1.2. Financials
8.1.3. Therapy portfolio
8.1.4. Business strategy
8.1.5. Recent developments
8.2. Johnson Johnson
8.2.1. Overview
8.2.2. Financials
8.2.3. Therapy portfolio
8.2.4. Business strategy
8.2.5. Recent developments
8.3. Daiichi Sankyo Company Limited
8.3.1. Overview
8.3.2. Financials
8.3.3. Therapy portfolio
8.3.4. Business strategy
8.3.5. Recent developments
8.4. H Lundbeck A/S
8.4.1. Overview
8.4.2. Financials
8.4.3. Therapy portfolio
8.4.4. Business strategy
8.4.5. Recent developments
8.5. Eisai Co Ltd.
8.5.1. Overview
8.5.2. Financials
8.5.3. Therapy portfolio
8.5.4. Business strategy
8.5.5. Recent developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll